Financial News
FDA grants accelerated approval for Biogen ALS drug that treats rare form of the disease
April 25, 2023 at 13:20 PM EDT
The FDA's approval requires Biogen to further study its ALS drug tofersen to further verify its clinical benefits.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
